300239 東寶生物
按盤價 
5.240 +0.160 (+3.150%)
5.240 +0.160 (+3.150%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.554 | 7.524 | 7.416 | 3.024 | 1.864 |
| 總資產報酬率 ROA (%) | 0.945 | 4.748 | 4.952 | 2.067 | 1.350 |
| 投入資產回報率 ROIC (%) | 1.147 | 5.937 | 6.498 | 2.708 | 1.654 | 邊際利潤分析 |
| 銷售毛利率 (%) | 20.844 | 25.532 | 24.744 | 15.710 | 15.542 |
| 營業利潤率 (%) | 13.884 | 14.764 | 13.835 | 6.811 | 4.402 |
| 息稅前利潤/營業總收入 (%) | 12.832 | 14.699 | 14.187 | 7.116 | 5.607 |
| 淨利潤/營業總收入 (%) | 11.615 | 13.070 | 12.236 | 5.852 | 4.054 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 97.601 | 97.068 | 94.050 | 76.278 | 67.535 |
| 價值變動淨收益/利潤總額(%) | -3.541 | -2.996 | -1.451 | -6.084 | -7.109 |
| 營業外收支淨額/利潤總額(%) | -2.575 | 0.425 | 0.860 | -0.368 | -0.468 | 償債能力分析 |
| 流動比率 (X) | 4.817 | 4.485 | 3.238 | 2.118 | 1.380 |
| 速動比率 (X) | 3.776 | 3.549 | 2.233 | 1.297 | 0.561 |
| 資產負債率 (%) | 30.235 | 30.956 | 23.927 | 24.078 | 0.296 |
| 帶息債務/全部投入資本 (%) | 22.956 | 22.027 | 10.556 | 3.565 | 6.788 |
| 股東權益/帶息債務 (%) | 320.085 | 336.709 | 803.161 | 2,548.934 | 1,292.166 |
| 股東權益/負債合計 (%) | 202.145 | 195.338 | 276.775 | 279.738 | 235.844 |
| 利息保障倍數 (X) | -18.245 | -114.321 | 60.964 | 21.540 | 4.575 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 61.470 | 56.917 | 56.585 | 72.317 | 79.367 |
| 存貨周轉天數 (天) | 135.730 | 148.666 | 168.312 | 220.673 | 246.056 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/04/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
